Natalie L. Rasgon

Clinical Focus

• Psychiatry

Administrative Appointments

• Departmental Senator, Stanford School of Medicine (2006 - present)
• AdministrativePanel on Human Subjects in Medical Research, Stanford University, (2004 - present)
• Advisory Board on Women’s Health, Stanford Unviversity (2004 - present)
• Member, Scholar Universe Neuroscience (2004 - present)
• Alternate Senator, Stanford School of Medicine (2004 - 2006)
View All 13administrative appointments of Natalie Rasgon

Honors and Awards

• International Scientist of the Year, International Biographical Centre of Cambridge, England (2002)
• Leo G. Rigler, M.D. Award for Academic Achievement, Cedars-Sinai Medical Center (1995)
• Diploma with Highest Honors, Odessa Medical Institute (1980)
• First Prize, Student Research Work, Soviet Union Scientific Student Competition (1978)
• First Prize, Philosophy Division, Ukraine Scientific Student Competition (1977)

Professional Education

Web Site Links

• Behavioral Neuroendocrinology Program

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Research Interests

Dr. Rasgon is a Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology in the Stanford School of Medicine. Before joining Stanford in October 2002, Dr. Rasgon obtained an M.D. from the U.S.S.R. in 1980, a Ph.D. in Reproductive Endocrinology in 1988 from the Central Institute of Postgraduate Medical Education, and a Ph.D. in Pathological Physiology from the Central Research Institute of General Pathology & Pathological Physiology Academy of Medical Sciences, Moscow, USSR. In addition, Dr. Rasgon was an NSRA Research Fellow at the Neuropsychiatric Institute, UCLA School of Medicine from 1995-1996, an Assistant Clinical Professor, Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Neuropsychiatric Institute and Hospital, and the Director of the UCLA Menopause-Related Mood Disorders Program, UCLA Neuropsychiatric Institute and Hospital.

Dr. Rasgon has been involved in longitudinal placebo-controlled neuroendocrine studies for nearly two decades, and she has been involved in neuroendocrine and brain imaging studies of estrogen effects on depressed menopausal women for the last eight years. It should be noted that in addition to her duties as a Professor of Psychiatry and Obstetrics & Gynecology, Dr. Rasgon is also the Director of the Behavioral Neuroendocrinology Program and the Women's Wellness Program in the Department of Psychiatry. Research in the Behavioral Neuroendocrinology Program, which Dr. Rasgon founded, focuses on the interaction between reproductive hormones and brain function. Research efforts of the lab are concentrated in two areas: (1) the reproductive endocrine status of women with affective disorders, and (2) the neurobiology of the effects of hormone therapy in aging women.

Clinical Trials

• Estrogen Use in Protection from Cognitive Decline No longer recruiting

Publications

• Insulin resistance and hyperlipidemia in women with bipolar disorder. Stemmle PG, Kenna HA, Wang PW, Hill SJ, Ketter TA, Rasgon NL. J Psychiatr Res. 2009; 43 (3): 341-3
• Relationship among latitude, climate, season and self-reported mood in bipolar disorder. Bauer M, Glenn T, Grof P, Rasgon NL, Marsh W, Sagduyu K, Alda M, Murray G, Quiroz D, Malliaris Y, Sasse J, Pilhatsch M, Whybrow PC. J Affect Disord. 2009; 116 (1-2): 152-7
• Comparison of sleep/wake parameters for self-monitoring bipolar disorder. Bauer M, Glenn T, Grof P, Rasgon N, Alda M, Marsh W, Sagduyu K, Schmid R, Adli M, Whybrow PC. J Affect Disord. 2009; 116 (3): 170-5
• Increased depressive symptoms in menopausal age women with bipolar disorder: age and gender comparison. Marsh WK, Ketter TA, Rasgon NL. J Psychiatr Res. 2009; 43 (8): 798-802
• Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, Taylor VH, Woldeyohannes HO, Alsuwaidan MT, Soczynska JK, Kim B, Lourenco MT, Kahn LS, Goldstein BI. Curr Diab Rep. 2009; 9 (1): 51-9